Literature DB >> 20303193

Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.

Lili Chen1, Kamen Paskalev, Xiu Xu, Jennifer Zhu, Lu Wang, Robert A Price, Wei Hu, Steven J Feigenberg, Eric M Horwitz, Alan Pollack, C M Charlie Ma.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the change in rectal dose during the treatment course for intensity-modulated radiotherapy (IMRT) of prostate cancer with image-guidance.
MATERIALS AND METHODS: Twenty prostate cancer patients were recruited for this retrospective study. All patients have been treated with IMRT. For each patient, MR and CT images were fused for target and critical structure delineation. IMRT treatment planning was performed on the simulation CT images. Inter-fractional motion during the course of treatment was corrected using a CT-on-rails system. The rectum was outlined on both the original treatment plan and the subsequent daily CT images from the CT-on-rails by the same investigator. Dose distributions on these daily CT images were recalculated with the isocenter shifts relative to the simulation CT images using the leaf sequences/MUs based on the original treatment plan. The rectal doses from the subsequent daily CTs were compared with the original doses planned on the simulation CT using our clinical acceptance criteria.
RESULTS: Based on 20 patients with 139 daily CT sets, 28% of the subsequent treatment dose distributions did not meet our criterion of V(40) < 35%, and 27% did not meet our criterion of V(65) < 17%. The inter-fractional rectal volume variation is significant for some patients.
CONCLUSIONS: Due to the large inter-fractional variation of the rectal volume, it is more favorable to plan prostate IMRT based on an empty rectum and deliver treatment to patients with an empty rectum. Over 70% of actual treatments showed better rectal doses than our clinical acceptance criteria. A significant fraction (27%) of the actual treatments would benefit from adaptive image-guided radiotherapy based on daily CT images. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20303193     DOI: 10.1016/j.radonc.2010.02.023

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.

Authors:  Jialu Yu; Nicholas Hardcastle; Kyoungkeun Jeong; Edward T Bender; Mark A Ritter; Wolfgang A Tomé
Journal:  Technol Cancer Res Treat       Date:  2014-11-11

2.  Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.

Authors:  Michael Wahl; Martina Descovich; Erin Shugard; Dilini Pinnaduwage; Atchar Sudhyadhom; Albert Chang; Mack Roach; Alexander Gottschalk; Josephine Chen
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

3.  Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.

Authors:  Maria Thor; Aditya Apte; Joseph O Deasy; Ludvig Paul Muren
Journal:  Acta Oncol       Date:  2012-12-04       Impact factor: 4.089

4.  Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.

Authors:  Lynsey Devlin; David Dodds; Azmat Sadozye; Philip McLoone; Nicholas MacLeod; Carolynn Lamb; Suzanne Currie; Stefanie Thomson; Aileen Duffton
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

5.  Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer.

Authors:  Shinya Takemoto; Yuta Shibamoto; Shiho Ayakawa; Aiko Nagai; Akihiro Hayashi; Hiroyuki Ogino; Fumiya Baba; Takeshi Yanagi; Chikao Sugie; Hiromi Kataoka; Mikio Mimura
Journal:  Radiat Oncol       Date:  2012-06-12       Impact factor: 3.481

Review 6.  Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment.

Authors:  J E Scaife; G C Barnett; D J Noble; R Jena; S J Thomas; C M L West; N G Burnet
Journal:  Br J Radiol       Date:  2015-05-26       Impact factor: 3.039

7.  Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion.

Authors:  J Scaife; K Harrison; M Romanchikova; A Parker; M Sutcliffe; S Bond; S Thomas; S Freeman; R Jena; A Bates; N Burnet
Journal:  Br J Radiol       Date:  2014-08-20       Impact factor: 3.039

8.  Recalculation of dose for each fraction of treatment on TomoTherapy.

Authors:  Simon J Thomas; Marina Romanchikova; Karl Harrison; Michael A Parker; Amy M Bates; Jessica E Scaife; Michael P F Sutcliffe; Neil G Burnet
Journal:  Br J Radiol       Date:  2016-01-05       Impact factor: 3.039

9.  Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer.

Authors:  Jessica E Scaife; Simon J Thomas; Karl Harrison; Marina Romanchikova; Michael P F Sutcliffe; Julia R Forman; Amy M Bates; Raj Jena; M Andrew Parker; Neil G Burnet
Journal:  Br J Radiol       Date:  2015-07-24       Impact factor: 3.039

10.  Intrafractional prostate motion during external beam radiotherapy monitored by a real-time target localization system.

Authors:  Xu Tong; Xiaoming Chen; Jinsheng Li; Qianqian Xu; Mu-Han Lin; Lili Chen; Robert A Price; Chang-Ming Ma
Journal:  J Appl Clin Med Phys       Date:  2015-03-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.